In HCM troponin I and MYBPC3, mutations have been associated in some cases with more asymmetric septal hypertrophy [40,41], which corresponds to the finding in our study that the abundance of these proteins is strong in the intraventricular septum. Here, MYBPC3 is linked to hypertrophy.